Not all asthma is created equal, nor will all therapies work for all patients. With continued innovations in asthma treatments offering new, improved options for patients, we are more prepared than ...
Patients with mild asthma exposed to higher levels of O3 and NO2, but not PM2.5, were associated with an increased risk for asthma exacerbation.
The most common asthma inhaler for children was discontinued at the start of this year, forcing parents and pediatricians to scramble to switch to an alternative. But more than a month later, the ...
Budget impact analysis finds omalizumab biosimilars in Europe could cut payer costs by €641M in 5 years, expanding access and ...
Please provide your email address to receive an email when new articles are posted on . Patients with allergic rhinitis and comorbid asthma had poorer health-related quality of life and symptom ...
A recent study found that a sizable portion of the commercially insured asthma population lacks disease control, regardless of asthma severity, signaling a needed shift in treatment strategies.
ATLANTA - Prices are rising sharply on many asthma inhalers just in time for spring allergy season and some insurance companies are not covering the higher costs, and many patients cannot afford the ...
Asthma-related emergency department (ED) visits jumped significantly on days when thunderstorms occurred, based on data from more than 4000 visits. The findings were presented at the American College ...
PHOENIX -- Biologic medications sent severe asthma into remission in a substantial proportion of patients, according to a study presented here at the annual meeting of the American Academy of Allergy, ...
In 2017, an expert commission organized by the Lancet examined the current state of asthma care. That commission identified poor medication adherence as one of the principal barriers standing between ...
Just about everyone with asthma knows the drill. Take a daily snort of a prescription inhaler filled with a steroid that helps fight inflammation, to prevent trouble. Not everyone actually does this, ...